Kuros Biosciences Forecast, price target & analysts
Kuros Biosciences Target price 2025 - Analyst rating & recommendation
Kuros Biosciences Classifications & Recommendation:
Kuros Biosciences Price Target
| Target Price | CHF32.39 |
| Price | CHF28.48 |
| Potential |
13.71%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Kuros Biosciences 2026 .
The average Kuros Biosciences target price is CHF32.39.
This is
13.71%
register free of charge
CHF34.13
19.82%
register free of charge
CHF31.31
9.94%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend Kuros Biosciences to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Kuros Biosciences stock has an average upside potential 2026 of
13.71%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million CHF | 75.04 | 109.33 |
| 125.07% | 46.28% | |
| EBITDA Margin | 1.01% | 5.19% |
| 107.73% | 410.40% |
4 Analysts have issued a sales forecast Kuros Biosciences 2025 . The average Kuros Biosciences sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Kuros Biosciences EBITDA forecast 2025. The average Kuros Biosciences EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | -0.10 | 0.05 |
| 72.97% | 150.00% | |
| P/E | 598.83 |
4 Analysts have issued a Kuros Biosciences forecast for earnings per share. The average Kuros Biosciences EPS is
This results in the following potential growth metrics and future valuations:
Kuros Biosciences...
Current Kuros Biosciences Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Aug 14 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Aug 14 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
